Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Inventory (2017 - 2025)

Inspire Medical Systems' Inventory history spans 9 years, with the latest figure at $145.3 million for Q4 2025.

  • For Q4 2025, Inventory rose 81.35% year-over-year to $145.3 million; the TTM value through Dec 2025 reached $145.3 million, up 81.35%, while the annual FY2025 figure was $145.3 million, 81.35% up from the prior year.
  • Inventory for Q4 2025 was $145.3 million at Inspire Medical Systems, up from $141.8 million in the prior quarter.
  • Across five years, Inventory topped out at $145.3 million in Q4 2025 and bottomed at $11.4 million in Q1 2021.
  • The 5-year median for Inventory is $24.2 million (2022), against an average of $49.5 million.
  • The largest annual shift saw Inventory tumbled 31.02% in 2022 before it skyrocketed 212.67% in 2024.
  • A 5-year view of Inventory shows it stood at $17.2 million in 2021, then tumbled by 31.02% to $11.9 million in 2022, then skyrocketed by 185.08% to $33.9 million in 2023, then surged by 136.44% to $80.1 million in 2024, then soared by 81.35% to $145.3 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Inventory are $145.3 million (Q4 2025), $141.8 million (Q3 2025), and $121.6 million (Q2 2025).